➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Boehringer Ingelheim
Mallinckrodt
Harvard Business School
Express Scripts

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

DIETHYLPROPION HYDROCHLORIDE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for diethylpropion hydrochloride and what is the scope of freedom to operate?

Diethylpropion hydrochloride is the generic ingredient in five branded drugs marketed by Lannett Co Inc, Sanofi Aventis Us, Nostrum Labs Inc, 3M, Avanthi Inc, Chartwell Rx, Epic Pharma Llc, Sandoz, Teva, Ucb Inc, and Watson Labs, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for diethylpropion hydrochloride. Ten suppliers are listed for this compound.

Recent Clinical Trials for DIETHYLPROPION HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKlineN/A
New River PharmaceuticalsPhase 1/Phase 2

See all DIETHYLPROPION HYDROCHLORIDE clinical trials

Pharmacology for DIETHYLPROPION HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DIETHYLPROPION HYDROCHLORIDE

US Patents and Regulatory Information for DIETHYLPROPION HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Avanthi Inc DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 201212-001 Dec 22, 2010 AA RX No No   Start Trial   Start Trial   Start Trial
Watson Labs DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 085741-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Chartwell Rx DIETHYLPROPION HYDROCHLORIDE diethylpropion hydrochloride TABLET;ORAL 088268-001 Aug 25, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.